日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

In vitro evolution of antibody affinity via insertional scanning mutagenesis of an entire antibody variable region

通过插入扫描诱变整个抗体可变区来体外进化抗体亲和力

Kalliopi Skamaki, Stephane Emond, Matthieu Chodorge, John Andrews, D Gareth Rees, Daniel Cannon, Bojana Popovic, Andrew Buchanan, Ralph R Minter, Florian Hollfelder

Engineering of a GLP-1 analogue peptide/anti-PCSK9 antibody fusion for type 2 diabetes treatment

设计 GLP-1 类似肽/抗 PCSK9 抗体融合物用于 2 型糖尿病治疗

Matthieu Chodorge, Anthony J Celeste, Joseph Grimsby, Anish Konkar, Pia Davidsson, David Fairman, Lesley Jenkinson, Jacqueline Naylor, Nicholas White, Jonathan C Seaman, Karen Dickson, Benjamin Kemp, Jennifer Spooner, Emmanuel Rossy, David C Hornigold, James L Trevaskis, Nicholas J Bond, Timothy B L

MEDI1873, a potent, stabilized hexameric agonist of human GITR with regulatory T-cell targeting potential

MEDI1873,一种强效、稳定的人类 GITR 六聚体激动剂,具有调节性 T 细胞靶向潜力

Natalie J Tigue, Lisa Bamber, John Andrews, Samantha Ireland, James Hair, Edward Carter, Sudharsan Sridharan, Jelena Jovanović, D Gareth Rees, Jeremy S Springall, Emilie Solier, Yi-Ming Li, Matthieu Chodorge, David Perez-Martinez, Daniel R Higazi, Michael Oberst, Maureen Kennedy, Chelsea M Black, Li

A Shorter Route to Antibody Binders via Quantitative in vitro Bead-Display Screening and Consensus Analysis

通过定量体外微珠展示筛选和一致性分析实现抗体结合剂的更短途径

Sylwia A Mankowska, Pietro Gatti-Lafranconi, Matthieu Chodorge, Sudharsan Sridharan, Ralph R Minter, Florian Hollfelder

Human monomeric antibody fragments to TRAIL-R1 and TRAIL-R2 that display potent in vitro agonism

针对 TRAIL-R1 和 TRAIL-R2 的人类单体抗体片段,具有强效体外激动作用

Claire L Dobson, Sarah Main, Philip Newton, Matthieu Chodorge, Karen Cadwallader, Robin Humphreys, Vivian Albert, Tristan J Vaughan, Ralph R Minter, Bryan M Edwards